Pulmonary Function Testing and Outcomes after Left Ventricular Assist Device Implantation

Area of Science:

• Cardiology
• Pulmonology
• Medical Devices

Background:

• Pulmonary function testing (PFT) is commonly performed before left ventricular assist device (LVAD) implantation.
• The predictive value of baseline PFT for post-LVAD outcomes and changes in pulmonary function remains unclear.

Purpose of the Study:

• To assess the association between baseline PFT metrics and post-LVAD outcomes.
• To quantify changes in pulmonary function after LVAD implantation.

Main Methods:

• Retrospective study of 178 patients with continuous flow LVADs.
• Analysis of baseline PFT data (FEV1, FVC, FEV1/FVC, DLCO) in 129 patients, with repeat testing in 54.
• Statistical analysis including proportional hazards and linear regressions, and paired t-tests.

Main Results:

• No association found between baseline PFT parameters and post-LVAD survival or perioperative right heart failure.
• Baseline PFT metrics did not correlate with changes in quality of life (KCCQ) or functional capacity (6MWD).
• Statistically significant declines observed in FEV1, FEV1/FVC ratio, and DLCO post-LVAD.

Conclusions:

• Baseline PFTs did not predict outcomes in patients receiving LVADs.
• Pulmonary function parameters frequently worsened after LVAD implantation.
• Further research is required to establish the utility of PFTs in LVAD management and understand LVAD's impact on lung function.